Jazz Pharmaceuticals plc
US ˙ NasdaqGS ˙ IE00B4Q5ZN47

SecurityJAZZ / Jazz Pharmaceuticals plc
InstitutionNeuberger Berman Group LLC
Latest Disclosed Ownership9,284 shares
Latest Disclosed Value $ 1,755,140
Neuberger Berman Group LLC reports 2.24% increase in ownership of JAZZ / Jazz Pharmaceuticals plc

On May 14, 2026 - Neuberger Berman Group LLC filed a 13F-HR form disclosing ownership of 9,284 shares of Jazz Pharmaceuticals plc (US:JAZZ) valued at $1,755,140 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 9,081 shares of Jazz Pharmaceuticals plc. This represents a change in shares of 2.24% during the quarter. The current value of the position is $2,143,954 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F JAZZ PHARMACEUTICALS Common G50871105 9,284 203 2.24 1,755 13.74 0.0007
2026-02-13 2025-12-31 13F JAZZ PHARMACEUTICALS Common G50871105 9,081 1,134 14.27 1,544 47.37 0.0011
2025-11-12 2025-09-30 13F JAZZ PHARMACEUTICALS Common G50871105 7,947 2,295 40.61 1,047 74.79 0.0008
2025-08-25 2025-06-30 13F/A-1 JAZZ PHARMACEUTICALS Common G50871105 5,652 -3,075 -35.24 600 -44.69 0.0005
2025-08-13 2025-06-30 13F JAZZ PHARMACEUTICALS Common G50871105 5,652 -3,075 600 0.0002
2025-05-13 2025-03-31 13F JAZZ PHARMACEUTICALS Common G50871105 8,727 -263 -2.93 1,083 -2.17 0.0009
2025-02-13 2024-12-31 13F JAZZ PHARMACEUTICALS Common G50871105 8,990 -357 -3.82 1,107 6.34 0.0009
2024-11-14 2024-09-30 13F JAZZ PHARMACEUTICALS Common G50871105 9,347 2,130 29.51 1,041 35.19 0.0008
2024-11-14 2024-06-30 13F/A-1 JAZZ PHARMACEUTICALS Common G50871105 7,217 -133 -1.81 770 -12.99 0.0006
2024-08-13 2024-06-30 13F JAZZ PHARMACEUTICALS Common G50871105 7,217 -133 770 0.0006
2024-11-14 2024-03-31 13F/A-1 JAZZ PHARMACEUTICALS Common G50871105 7,350 601 8.91 885 6.63 0.0007
2024-05-13 2024-03-31 13F JAZZ PHARMACEUTICALS Common G50871105 7,350 601 885 0.0007
2024-11-14 2023-12-31 13F/A-2 JAZZ PHARMACEUTICALS Common G50871105 6,749 -276 -3.93 830 -8.69 0.0007
2024-02-09 2023-12-31 13F JAZZ PHARMACEUTICALS Common G50871105 6,749 -276 830 0.0007
2023-11-14 2023-09-30 13F JAZZ PHARMACEUTICALS Common G50871105 7,025 1,259 21.83 909 27.31 0.0008
2023-08-11 2023-06-30 13F JAZZ PHARMACEUTICALS Common G50871105 5,766 1,476 34.41 715 13.88 0.0006
2023-05-12 2023-03-31 13F JAZZ PHARMACEUTICALS Common G50871105 4,290 476 12.48 628 3.29 0.0006
2023-02-13 2022-12-31 13F JAZZ PHARMACEUTICALS Common G50871105 3,814 -88 -2.26 608 16.73 0.0006
2022-11-15 2022-09-30 13F JAZZ PHARMACEUTICALS Common G50871105 3,902 -606 -13.44 520 -26.14 0.0005
2022-08-15 2022-06-30 13F JAZZ PHARMACEUTICALS Common G50871105 4,508 -678 -13.07 704 -12.76 0.0007
2022-05-23 2022-03-31 13F/A-1 JAZZ PHARMACEUTICALS Common G50871105 5,186 1,755 51.15 807 93.99 0.0007
2022-05-13 2022-03-31 13F JAZZ PHARMACEUTICALS Common G50871105 5,186 1,755 782 0.0003
2022-02-11 2021-12-31 13F JAZZ PHARMACEUTICALS Common G50871105 3,431 1,415 70.19 416 71.19 0.0003
2021-11-12 2021-09-30 13F JAZZ PHARMACEUTICALS Common G50871105 2,016 16 0.80 243 -26.36 0.0002
2021-08-13 2021-06-30 13F JAZZ PHARMACEUTICALS Common G50871105 2,000 73 3.79 330 12.63 0.0003
2021-05-13 2021-03-31 13F JAZZ PHARMACEUTICALS Common G50871105 1,927 -89 -4.41 293 -9.01 0.0003
2021-02-10 2020-12-31 13F JAZZ PHARMACEUTICALS Common G50871105 2,016 72 3.70 322 15.83 0.0003
2020-11-12 2020-09-30 13F JAZZ PHARMACEUTICALS Common G50871105 1,944 -64,414 -97.07 278 -96.20 0.0003
2020-08-13 2020-06-30 13F JAZZ PHARMACEUTICALS Common G50871105 66,358 20,004 43.15 7,322 58.38 0.0091
2020-05-14 2020-03-31 13F JAZZ PHARMACEUTICALS Common G50871105 46,354 -5,004 -9.74 4,623 -39.70 0.0070
2020-02-12 2019-12-31 13F JAZZ PHARMACEUTICALS Common G50871105 51,358 51,358 7,667 0.0089
2019-05-13 2019-03-31 13F JAZZ PHARMACEUTICALS Common G50871105 0 -2,814 -100.00 0 -100.00
2019-02-12 2018-12-31 13F JAZZ PHARMACEUTICALS Common G50871105 2,814 -106,988 -97.44 349 -98.11 0.0005
2018-11-16 2018-09-30 13F/A-1 JAZZ PHARMACEUTICALS Common G50871105 109,802 -143 -0.13 18,461 -2.55 0.0209
2018-11-13 2018-09-30 13F JAZZ PHARMACEUTICALS Common G50871105 109,802 -143 18,461
2018-08-13 2018-06-30 13F JAZZ PHARMACEUTICALS Common G50871105 109,945 -7,400 -6.31 18,944 6.92 0.0209
2018-05-08 2018-03-31 13F JAZZ PHARMACEUTICALS Common G50871105 117,345 0 0.00 17,718 12.13 0.0202
2018-02-14 2017-12-31 13F JAZZ PHARMACEUTICALS Common G50871105 117,345 0 0.00 15,801 -7.93 0.0182
2017-11-15 2017-09-30 13F JAZZ PHARMACEUTICALS COMMON STOCK G50871105 117,345 24,626 26.56 17,162 19.03 0.0215
2017-08-08 2017-06-30 13F JAZZ PHARMACEUTICALS COMMON STOCK G50871105 92,719 37,264 67.20 14,418 79.15 0.0185
2017-05-10 2017-03-31 13F JAZZ PHARMACEUTICALS COMMON STOCK G50871105 55,455 -53,750 -49.22 8,048 -32.41 0.0104
2017-02-06 2016-12-31 13F JAZZ PHARMACEUTICALS COMMON STOCK G50871105 109,205 -21,696 -16.57 11,907 -25.12 0.0160
2016-11-02 2016-09-30 13F ***JAZZ PHARMACEUTICALS COMMON STOCK G50871105 130,901 0 0.00 15,902 -14.03 0.0216
2016-08-05 2016-06-30 13F ***JAZZ PHARMACEUTICALS COMMON STOCK G50871105 130,901 33,401 34.26 18,498 45.32 0.0255
2016-05-06 2016-03-31 13F ***JAZZ PHARMACEUTICALS COMMON STOCK G50871105 97,500 21,000 27.45 12,729 18.38 0.0175
2016-01-28 2015-12-31 13F ***JAZZ PHARMACEUTICALS COMMON STOCK G50871105 76,500 -56,900 -42.65 10,753 -39.31 0.0141
2015-11-10 2015-09-30 13F ***JAZZ PHARMACEUTICALS COMMON STOCK G50871105 133,400 -10,650 -7.39 17,717 -30.15 0.0228
2015-07-31 2015-06-30 13F ***JAZZ PHARMACEUTICALS COMMON STOCK G50871105 144,050 -377 -0.26 25,363 1.63 0.0282
2015-05-06 2015-03-31 13F ***JAZZ PHARMACEUTICALS COMMON STOCK G50871105 144,427 8,578 6.31 24,956 32.47 0.0266
2014-05-05 2014-03-31 13F ***JAZZ PHARMACEUTICALS COMMON STOCK G50871105 135,849 29,209 27.39 18,839 39.59 0.0192
2014-02-11 2013-12-31 13F ***JAZZ PHARMACEUTICALS COMMON STOCK G50871105 106,640 -64,710 -37.76 13,496 -14.36 0.0139
2013-10-29 2013-09-30 13F/A-1 ***JAZZ PHARMACEUTICALS COMMON STOCK G50871105 171,350 171,350 15,759 0.0175
2013-10-29 2013-09-30 13F ***JAZZ PHARMACEUTICALS COMMON STOCK G50871105 47,731 2,314 0.0030
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.